- Title
- A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
- Creators
- Barry C Johnson - HIV Drug Resistance Program, National Cancer Institute, Frederick National Laboratory for Cancer Research, P.O. Box B, Building 539, Room 130A, Frederick, MD, 21702-1201, USAGary T Pauly - Chemical Biology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USAGanesha Rai - NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, MSC 3370, USADisha Patel - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USAJoseph D Bauman - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USAHeather L Baker - NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, MSC 3370, USAKalyan Das - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USAJoel P Schneider - Chemical Biology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USADavid J Maloney - NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, MSC 3370, USAEddy Arnold - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USACraig J Thomas - NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, MSC 3370, USAStephen H Hughes - HIV Drug Resistance Program, National Cancer Institute, Frederick National Laboratory for Cancer Research, P.O. Box B, Building 539, Room 130A, Frederick, MD, 21702-1201, USA
- Publication Details
- Retrovirology, Vol.9(1), pp.99-99
- Date published
- 12/05/2012
- Publisher
- BioMed Central
- Academic Unit
- Center for Advanced Biotechnology and Medicine
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031654686504646
Journal article
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
Retrovirology, Vol.9(1), pp.99-99
12/05/2012
PMCID: PMC3549755
PMID: 23217210
Metrics
8 Record Views